Fournier, Dominique

Inflammation Is Associated with the Remodeling of Calcific Aortic Valve Disease

Coté, N., Mahmut, A., Bosse, Y., Couture, C., Pagé, S., Trahan, S., Boulanger, M.-C., Fournier, D., Pibarot, P., & Mathieu, P. (2013) · Inflammation

Cardiac Valve Diseases and TreatmentsStreptococcal Infections and Treatments

Cited by 218

P2Y2 receptor represses IL-6 expression by valve interstitial cells through Akt: implication for calcific aortic valve disease

El Husseini, D., Boulanger, M.-C., Mahmut, A., Bouchareb, R., Laflamme, M.-H., Fournier, D., Pibarot, P., Bossé, Y., & Mathieu, P. (2014) · Journal of Molecular and Cellular Cardiology

Cardiac Valve Diseases and TreatmentsAdenosine and Purinergic Signaling

Cited by 150

Refining molecular pathways leading to calcific aortic valve stenosis by studying gene expression profile of normal and calcified stenotic human aortic valves

Bossé, Y., Miqdad, A., Fournier, D., Pépin, A., Pibarot, P., & Mathieu, P. (2009) · Circulation: Cardiovascular Genetics

Cardiac Valve Diseases and TreatmentsAortic Disease and Treatment Approaches

Cited by 148

ATP acts as a survival signal and prevents the mineralization of aortic valve

Côté, N., El Husseini, D., Pépin, A., Guauque-Olarte, S., Ducharme, V., Bouchard-Cannon, P., Audet, A., Fournier, D., Gaudreault, N., Derbali, H., et al. (2012) · Journal of Molecular and Cellular Cardiology

Adenosine and Purinergic SignalingCardiac Valve Diseases and Treatments

Cited by 95

Lipoprotein lipase in aortic valve stenosis is associated with lipid retention and remodelling

Mahmut, A., Boulanger, M., Fournier, D., Couture, C., Trahan, S., Pagé, S., Arsenault, B., Després, J., Pibarot, P., & Mathieu, P. (2013) · European Journal of Clinical Investigation

Cardiac Valve Diseases and TreatmentsAtherosclerosis and Cardiovascular Diseases

Cited by 31